Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of <i>P. aeruginosa</i>?

Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of <i>P. aeruginosa</i>?

The development and testing of new antimicrobial peptides (AMPs) represent an important milestone toward the development of new antimicrobial drugs that can inhibit the growth of pathogens and multidrug-resistant microorganisms such as <i>Pseudomonas aeruginosa,</i> Gram-negative bacteri...

Full description

Bibliographic Details
Main Authors: Sergei Y. Grishin, Pavel A. Domnin, Sergey V. Kravchenko, Viacheslav N. Azev, Leila G. Mustaeva, Elena Y. Gorbunova, Margarita I. Kobyakova, Alexey K. Surin, Maria A. Makarova, Stanislav R. Kurpe, Roman S. Fadeev, Alexey S. Vasilchenko, Victoria V. Firstova, Svetlana A. Ermolaeva, Oxana V. Galzitskaya
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
ribosomal S1 protein
amyloid
antimicrobial peptides
<i>Pseudomonas aeruginosa</i>
cell penetrating peptide
Online Access:https://www.mdpi.com/1422-0067/22/18/9776

Internet

https://www.mdpi.com/1422-0067/22/18/9776

Similar Items